Oxford Biomedica PLC
23 March 2000
Oxford BioMedica ('the Company')
On 22 March 2000, the company granted options to Directors
over 1p ordinary shares as follows:
Director Options Exercise Date
price (p) Exercisable
Neill Moray MacKenzie 51,130 82.5 22.03.00-
22.03.07
Andrew Brian Wood 56,636 82.5 22.03.00-
22.03.07
Paul Kenneth Durrands 460,606 (1) 82.5 22.03.00-
22.03.07
(1) These options were granted on condition of Paul Durrands
becoming an employee of the Company. This became
effective on Tuesday 21 March 2000.
The above options have all been granted under the Oxford
BioMedica 1996 (1) Share Option Scheme with the exception of
those referred to in note (1) above which have been granted
under the terms of an individual option contact.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.